Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Blood-based Assay for Gastric Cancer Early Detection Using Multi-dimensional Analysis of Cell Free DNA Whole Methylome Sequencing-Protocol for an Observational, Case-control Study

NCT05668910 is registered in ClinicalTrials.gov with GeneCast Biotechnology Co., Ltd. as lead sponsor.

NCT NCT05668910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05668910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Blood-based Assay for Gastric Cancer Early Detection Using Multi-dimensional Analysis of Cell Free DNA Whole Methylome Sequencing-Protocol for an Observational, Case-control Study
Lead sponsor
GeneCast Biotechnology Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2022
Completion date
March 31, 2024
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer